Fennec Pharmaceuticals Inc banner
F

Fennec Pharmaceuticals Inc
NASDAQ:FENC

Watchlist Manager
Fennec Pharmaceuticals Inc
NASDAQ:FENC
Watchlist
Price: 7.65 USD 2.41%
Market Cap: $261.2m

Wall Street
Price Targets

FENC Price Targets Summary
Fennec Pharmaceuticals Inc

Wall Street analysts forecast FENC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FENC is 15.64 USD with a low forecast of 13.13 USD and a high forecast of 18.9 USD.

Lowest
Price Target
13.13 USD
72% Upside
Average
Price Target
15.64 USD
104% Upside
Highest
Price Target
18.9 USD
147% Upside
Fennec Pharmaceuticals Inc Competitors:
Price Targets
EXPO
Exponent Inc
37% Upside
FAST
Fastenal Co
2% Upside
ACIU
AC Immune SA
211% Upside
QXO
SilverSun Technologies Inc
62% Upside

Revenue
Forecast

N/A
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate of Fennec Pharmaceuticals Inc's revenue for the next 4 years is 30%.

Operating Income
Forecast

N/A
Past Growth
121% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
121% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

The compound annual growth rate of Fennec Pharmaceuticals Inc's operating income for the next 4 years is 121%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FENC's stock price target?
Price Target
15.64 USD

According to Wall Street analysts, the average 1-year price target for FENC is 15.64 USD with a low forecast of 13.13 USD and a high forecast of 18.9 USD.

What is Fennec Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
30%

The compound annual growth rate of Fennec Pharmaceuticals Inc's revenue for the next 4 years is 30%.

What is Fennec Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
121%

The compound annual growth rate of Fennec Pharmaceuticals Inc's operating income for the next 4 years is 121%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett